Drugs / ST-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05707208 | Mar 2023 → Dec 2025 | chronic pain syndrome | Sustained Therapeutics Inc. | Completed | Met primary |
News releases announcing trial results or a regulatory action · 3
| Date | Issuer | Release |
|---|---|---|
| 2026-05-19 | Sustained Therapeutics Inc. | Results Sustained Therapeutics Presents Positive Phase 2 Data for ST-01 in Podium Presentation at the American Urological Association 2026 Annual Meeting sustainedtherapeutics.com ↗
In the randomized Phase 2 study, ST-01 demonstrated statistically significant improvements in pain reduction and clinical response rates at the 70 mg/mL dose compared to standard of care alone. |
| 2026-01-08 | Sustained Therapeutics Inc. | Results Sustained Therapeutics Reports Positive Phase 2 Results for its Long-Acting Non-Opioid Medication for Chronic Pain sustainedtherapeutics.com ↗
Vancouver, Canada – Sustained Therapeutics Inc. (“Sustained Therapeutics” or the “Company”), a clinical-stage therapeutics company developing a non-opioid treatment for pain, today announced positive results from its Phase 2 clinical trial evaluating ST-01, the Company’s novel sustained-release drug. |
| 2023-07-05 | Sustained Therapeutics Inc. | Results A successful phase 1 study of an injectable lidocaine paste for spermatic cord block in men with chronic scrotal content pain sustainedtherapeutics.com ↗ |
All press releases naming this drug 3 releases
| Date | Issuer | Release |
|---|---|---|
| 2026-05-19 | Sustained Therapeutics Inc. | Sustained Therapeutics Presents Positive Phase 2 Data for ST-01 in Podium Presentation at the American Urological Association 2026 Annual Meeting sustainedtherapeutics.com ↗ |
| 2026-01-08 | Sustained Therapeutics Inc. | Sustained Therapeutics Reports Positive Phase 2 Results for its Long-Acting Non-Opioid Medication for Chronic Pain sustainedtherapeutics.com ↗ |
| 2023-07-05 | Sustained Therapeutics Inc. | A successful phase 1 study of an injectable lidocaine paste for spermatic cord block in men with chronic scrotal content pain sustainedtherapeutics.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ST-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05707208 ↗ |
| Known as | Lidocaine Polymer Solution | “A Randomized, Controlled Phase II Study of Repeat Dose ST-01 (Lidocaine Polymer Solution) vs Lidocaine for Spermatic Cord Block in Men With Chronic Scrotal Content Pain” NCT05707208 ↗ |